Chow M P, Lin C K, Lin J S, Chau W K, Ho C H, Chen S Y, Lee S H, Yung C H
National Institute of Preventive Medicine, Department of Health, Taipei, Taiwan, R.O.C.
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1991 Nov;24(4):331-8.
For the purpose to clarifying the biologically active substance of B. pertussis, we prepared the filamentous hemagglutinin (FHA) from culture supernatant of the strain Tohama phase I and purified it through chromatography columns of hydroxylapatite, fetuin-Sepharose 4B and Sepharose CL 6B. There are several bands appeared in the polyacrylamide gel after SDS-PAGE, especially between 98 kD and 210 kD. The amount of 210 kD component is not proportional to hemagglutination (HA) activity of FHA among five different lots. Irons et al. reported that FHA preparation degraded the 220 kD and 210 kD polypeptides during the storage would be reduced the specific HA activity. Our result pointed out that the HA activity of purified Foffdid not relate to 210 kD component only. For the quality control of FHA purity in the B. pertussis acellular vaccine, we suggest that it would be necessary to test both HA titer and SDS-PAGE results.
为了阐明百日咳博德特氏菌的生物活性物质,我们从I相托哈马菌株的培养上清液中制备了丝状血凝素(FHA),并通过羟基磷灰石柱、胎球蛋白-琼脂糖4B柱和琼脂糖CL 6B柱对其进行了纯化。SDS-PAGE后,聚丙烯酰胺凝胶中出现了几条带,尤其是在98 kD和210 kD之间。在五个不同批次中,210 kD组分的量与FHA的血凝(HA)活性不成比例。艾恩斯等人报道,FHA制剂在储存过程中会降解220 kD和210 kD的多肽,这会降低特异性HA活性。我们的结果指出,纯化的FHA的HA活性不仅仅与210 kD组分有关。对于百日咳无细胞疫苗中FHA纯度的质量控制,我们建议有必要同时检测HA效价和SDS-PAGE结果。